A High-fat, High-salt Diet Model of MDAKD Impairs Bioenergetic Efficiency for ATP Synthesis

This study demonstrates that a high-fat, high-salt diet induces an early metabolic dysfunction-associated kidney disease (MDAKD) phenotype in C57BL/6 mice characterized by strain-specific functional responses, tubular injury, and fibrosis, driven primarily by diet-induced mitochondrial bioenergetic uncoupling that impairs ATP synthesis efficiency without causing obesity.

The Gist

The Big Picture: A "Stress Test" for Kidneys

Imagine your kidneys as a high-tech water filtration plant. Their main job is to clean your blood, remove waste, and balance your fluids. This plant runs on electricity (energy) and is staffed by thousands of tiny workers (cells) who do the heavy lifting.

This study asked a simple question: What happens to this filtration plant if we feed it a diet that is super high in fat and salt, but not enough to make the animal fat?

Usually, scientists study kidney disease by making mice obese or by surgically damaging their kidneys. But in the real world, many people get kidney problems from "metabolic stress" (bad diet) before they even become obese. The researchers wanted to create a model that mimics this specific, early stage of disease.

The Experiment: Two Types of Mice, One Bad Diet

The researchers used two very similar strains of mice, which we can think of as Twin A (6J) and Twin B (6N). They are genetically almost identical, but they have subtle differences in their "factory blueprints."

Both groups were fed a "junk food" diet for 16 weeks:

• High Fat: Like eating a lot of cheese and butter.
• High Salt: Like eating a bag of chips every day.

The Surprise:
Neither group of mice got fat. Their body weight and belly fat stayed the same. However, their kidneys got bigger (swollen from the work), and they drank and peed a lot more water to flush out all that salt.

The Results: How the "Twins" Reacted Differently

1. The Filtration Rate (GFR)

Think of the GFR as the speed at which the filtration plant processes water.

• Twin A (6J): The plant slowed down. The filtration rate dropped significantly. The kidney was struggling to keep up.
• Twin B (6N): The plant actually sped up slightly or stayed the same. This twin was surprisingly resilient, managing to keep the water flowing despite the bad diet.

2. The "Leak" (Kidney Injury)

Even though Twin B kept the water flowing, both twins showed signs of damage.

• Imagine the workers in the plant starting to leak tools and broken parts into the water stream.
• Both groups of mice started leaking specific "injury markers" (proteins like KIM-1 and NGAL) into their urine. This proved that the tubes inside the kidney were stressed and damaged, even if the overall filtration speed looked okay in Twin B.

3. The Power Plant Problem (Mitochondria)

This is the most important discovery. Inside every kidney cell is a tiny power plant called a mitochondrion. Its job is to burn fuel to make electricity (ATP) so the kidney workers can do their job.

• The Finding: The bad diet didn't break the power plants (the number of power plants was the same). But, the power plants became inefficient.
• The Analogy: Imagine a car engine. In a healthy kidney, the engine burns gas and turns the wheels efficiently. In these mice, the engine was still burning gas (consuming oxygen), but the wheels weren't turning as fast (less ATP produced). The energy was being wasted as heat instead of work.
• The Result: The kidney workers were exhausted. They were trying to pump salt and water, but they didn't have enough efficient energy to do it, leading to the "leaks" and damage we saw earlier.

Why Did the Twins React Differently?

The researchers found that Twin B (6N) had a secret weapon: Adaptation.

• Twin B's kidney workers started changing their uniforms. They adjusted the "gates" (transporters) that let salt and water in and out. They seemed to know how to handle the salt load better, protecting the filtration speed.
• Twin A (6J) didn't have this trick. They just took the hit, their filtration slowed down, and they got sicker.

The Takeaway for Humans

This study is like a warning label on a bag of chips and a bottle of soda.

1. You don't need to be fat to hurt your kidneys. Even if you stay thin, a diet high in fat and salt can stress your kidneys and damage the tiny power plants inside them.
2. Genetics matter. Some people (like Twin B) might have genes that help them resist this damage for a while, while others (like Twin A) might be more vulnerable.
3. The damage starts early. Before your kidneys fail completely, the "power plants" start getting inefficient. This is the early stage of disease that we need to catch.

In short: A high-fat, high-salt diet acts like a "silent stressor." It doesn't make you fat, but it forces your kidneys to work overtime with a broken engine, eventually leading to wear and tear. The study suggests that fixing the "engine efficiency" (mitochondrial health) could be the key to treating kidney disease in the future.

Technical Summary

1. Problem Statement

Chronic Kidney Disease (CKD) is a major global health burden, increasingly driven by Metabolic Dysfunction-Associated Kidney Disease (MDAKD). MDAKD is characterized by the convergence of obesity, metabolic dysregulation, and renal dysfunction.

• The Gap: Existing preclinical models fail to faithfully recapitulate the gradual, systemic progression of human MDAKD.
  • Surgical models (e.g., 5/6 nephrectomy) cause acute, severe injury rather than chronic, metabolic progression.
  • Genetic models address rare monogenic disorders but not common multifactorial pathogenesis.
  • Dietary models (high-fat or high-salt alone) often induce obesity or hypertension but rarely result in measurable declines in Glomerular Filtration Rate (GFR) or sustained CKD progression without obesity.
• The Hypothesis: There is a lack of a standardized, non-surgical murine paradigm that integrates systemic metabolic load, tubular injury, and mitochondrial dysfunction (a central mediator of CKD) to model early-stage MDAKD.

2. Methodology

The study utilized a comparative approach using two distinct substrains of C57BL/6 mice to assess genetic susceptibility.

• Animal Model:
  • Subjects: Male C57BL/6J (6J) and C57BL/6N (6N) mice (8–10 weeks old).
  • Intervention: 16-week feeding of either a standard chow diet or a High-Fat, High-Sodium (HF/HNa) diet (42% fat, ~8% salt).
  • Key Feature: The diet was designed to induce metabolic stress without inducing obesity (no significant change in body weight or adiposity).
• Physiological & Functional Assessments:
  • GFR: Measured via transcutaneous clearance of FITC-sinistrin.
  • Urinalysis: 24-hour urine collection for Albumin, Creatinine, Cystatin C, KIM-1, and NGAL.
  • Systemic Metrics: Body composition (NMR), water/food intake, and plasma BUN.
• Histopathology:
  • Staining with H&E, PAS, and Masson's Trichrome to assess fibrosis and morphology.
  • Image Analysis: Automated segmentation using Fiji, Labkit, and custom Python/MONAI scripts to quantify glomerular and tubular fibrosis.
• Mitochondrial Bioenergetics:
  • Isolation: Renal mitochondria isolated from kidney tissue.
  • Respirometry: High-resolution respirometry (Oroboros O2K) using a SUIT (Substrate-Uncoupler-Inhibitor Titration) protocol to measure Oxygen Consumption ($J_{O2}$).
  • ATP Production: Fluorometric quantification of ATP generation ($J_{ATP}$) and calculation of ATP:O ratios.
• Molecular Analysis:
  • Proteomics: Mass spectrometry (DIA-MS) of urinary proteins.
  • Western Blot & qPCR: Assessment of transporter abundance (AQP2, NKCC2, SGLT2), ER stress markers, inflammatory cytokines, and mitochondrial protein complexes (OXPHOS).

3. Key Contributions

1. Novel Non-Obese MDAKD Model: Established a 16-week HF/HNa diet model that induces renal injury and mitochondrial dysfunction independent of obesity or total caloric excess, closely mimicking the "metabolic stress without obesity" phenotype seen in some human MDAKD cases.
2. Strain-Dependent Susceptibility: Demonstrated that genetic background (6J vs. 6N) dictates the functional outcome of metabolic stress, with 6J mice showing GFR decline and 6N mice maintaining filtration, providing a tool to study resilience vs. susceptibility.
3. Mechanistic Insight into Bioenergetics: Identified mitochondrial uncoupling (reduced ATP production efficiency despite preserved oxygen consumption) as a primary, early driver of renal injury, occurring before overt fibrosis or inflammation.
4. Urinary Proteomic Biomarkers: Identified novel urinary markers (e.g., Villin-1, Atp6v0c, Sppl2a) associated with tubular stress and extracellular matrix remodeling in early MDAKD.

4. Key Results

A. Physiological & Systemic Effects

• Body Weight: HF/HNa feeding did not alter body weight, liver mass, or adiposity in either strain, confirming the model is non-obese.
• Fluid Balance: HF/HNa mice exhibited significantly increased water intake and urine output, indicating osmotic stress.
• Kidney Mass: Both strains showed increased kidney mass (hypertrophy) despite normal body weight.

B. Renal Function & Injury Markers

• GFR Divergence:
  • 6J Mice: Significant decline in GFR.
  • 6N Mice: GFR was maintained or slightly increased.
• Tubular Injury: Both strains showed elevated urinary markers of tubular stress: KIM-1, NGAL (Lcn2), and Cystatin C.
• Albuminuria: Urinary Albumin-Creatinine Ratio (ACR) increased significantly in 6J mice but was more variable in 6N mice.

C. Histopathology

• Fibrosis: Whole-kidney trichrome staining revealed increased fibrotic area in HF/HNa groups. The increase was significantly greater in 6N mice compared to 6J mice, despite 6N mice having preserved GFR.
• Glomerular Morphology: No significant changes in glomerular size, Bowman's space, or glomerular fibrosis were observed, suggesting the functional decline in 6J mice is driven by tubular/hemodynamic factors rather than glomerulosclerosis at this stage.

D. Molecular & Transporter Adaptations

• Transporters:
  • 6N Mice: Showed adaptive trends: increased AQP2 and decreased SGLT2 (potentially reducing osmotic load).
  • 6J Mice: No adaptive changes in transporters; showed increased mRNA for KIM-1.
• Stress Pathways: No significant changes in ER stress markers (BiP, CHOP, PERK) or canonical inflammatory pathways (NF-κB, TNF-α), suggesting injury is not driven by these classic pathways.

E. Mitochondrial Bioenergetics (Central Finding)

• Respiration: Oxygen consumption ($J_{O2}$) was preserved in both strains.
• ATP Synthesis: ATP production ($J_{ATP}$) and the ATP:O ratio were significantly reduced in HF/HNa groups for both strains.
• Interpretation: This indicates bioenergetic uncoupling. The mitochondria consume oxygen but fail to convert it efficiently into ATP. This is not due to a loss of mitochondrial mass (Citrate Synthase unchanged) or ETC protein abundance.
• Conclusion: The high metabolic demand of sodium reabsorption in the tubules exceeds mitochondrial capacity, leading to inefficient ATP synthesis.

F. Urinary Proteomics

• Identified upregulation of tubular structural proteins (Villin-1), proteostasis markers (Atp6v0c, Sppl2a, Pdcd6), and transport proteins (Sdha, Aldob, Slc22a19) in 6J mice, offering new potential biomarkers for early renal failure.

5. Significance & Conclusion

This study defines a robust, non-surgical model for early-stage MDAKD that isolates the effects of metabolic and osmotic stress from obesity.

• Mechanistic Shift: It challenges the view that inflammation or ER stress are the primary initiators of early MDAKD, proposing instead that mitochondrial bioenergetic inefficiency (uncoupling) is a central, early driver.
• Genetic Heterogeneity: The divergence between 6J (susceptible) and 6N (resilient) mice highlights that while mitochondrial dysfunction is a shared pathogenic mechanism, the outcome (GFR loss vs. preservation) depends on genetic adaptations in transporter regulation and hemodynamic control.
• Therapeutic Implications: The findings suggest that therapies targeting mitochondrial efficiency (e.g., improving coupling or reducing transport burden) could be effective in preventing CKD progression in patients with metabolic dysfunction, even before overt fibrosis or inflammation sets in.

The authors conclude that this model provides a critical platform for dissecting the mechanisms of diet-induced kidney disease and identifying novel therapeutic targets for preserving bioenergetic efficiency in the kidney.